ClinicalTrials.gg
Not yet recruitingNCT07887295PCITUpdated Oct 21, 2026

Hybrid Pilot of Personalized Parent-Child Interaction Therapy

An interventional study of Behavioral Parent Training in Disruptive Behaviors, sponsored by San Diego State University. Not yet recruiting at 2 sites in United States. Open to participants aged 2 Years to 6 Years. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by San Diego State University · Not applicable, Interventional, and Treatment

Updated Oct 21, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
2 Years to 6 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn whether a personalized version of Parent-Child Interaction Therapy (PCIT), called MY PCIT, can improve treatment fit, treatment participation, and outcomes for young children with behavior problems and their caregivers. The main questions this study aims to answer are:

  • How does standard PCIT compare to MY PCIT in keeping families engaged in treatment and improving treatment outcomes?
  • How does standard PCIT compare to MY PCIT in aligning treatment and families' beliefs and values?

Researchers will compare standard PCIT to MY PCIT to learn how the personalized approach can be delivered in community mental health settings, and whether it may improve treatment fit, reduce treatment dropout, and improve outcomes for children and their caregivers.

Participating families will:

  • Receive standard PCIT or MY PCIT
  • Complete four sets of online surveys: one before treatment, two during treatment, and one after treatment

The surveys will ask about the child's behavior and the family's beliefs, values, and treatment experiences. Researchers will also gather feedback from therapists to help improve how MY PCIT can be delivered and sustained in community mental health sites.

02

Conditions studied

  • Disruptive Behaviors

Keywords

  • Parent-Child Interaction Therapy
  • Personalized Treatment
  • Behavioral Parent Training
  • Community Mental Health Settings
  • Behavior Problems
03

In context

Problem Behavior

521 studies on the registry are indexed under Problem Behavior; 92 are open to participants now.

This study's planned enrollment of 60 is below the median of 90 across 393 interventional studies indexed under Problem Behavior.

Browse Problem Behavior studies →

Lead sponsor

San Diego State University is the lead sponsor of 147 studies on the registry; 43 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 6 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Caregiver 18 years or over
  • Caregiver seeking therapy for a child with behavior problems through a community mental health service agency that is participating in the study
  • Families are determined to be appropriate for the study by the participating community mental health service agency.
  • Child 2-6 years of age
  • Child has an ECBI intensity score in the clinical range
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Standard PCIT

    Parent-Child Interaction Therapy (PCIT) is a behavioral parent training intervention developed by Dr. Sheila Eyberg for young children (aged 2-7) with disruptive behavior problems. It is a well-established, evidence-based intervention that uses a live coaching model in which therapists use a one-way mirror or similar set-up to coach parents in specialized parenting skills in their interactions with their children. The intervention involves 2 segments: (1) Child Directed Interaction (CDI) focuses upon developing a positive, warm relationship between parent and child and using selective attention effectively. (2) Parent Directed Interaction (PDI) focuses upon teaching parents how to provide consistent and effective discipline.

    Behavioral: Behavioral Parent Training

  • Experimental
    MY PCIT (a personalized version of PCIT)

    MY PCIT is a version of PCIT that is personalized to each family with the aim to increase the match between the treatment's beliefs/values and the family's beliefs/values. MY PCIT includes an assessment of parental beliefs/values that will then guide adaptations to the delivery of PCIT.

    Behavioral: Behavioral Parent Training

Interventions

  • BehavioralBehavioral Parent Training

    Parent-Child Interaction Therapy

06

What researchers measure

Primary outcomes

  1. Eyberg Child Behavior Inventory (ECBI)

    Time frame: 1. Baseline 2. Post-treatment (on average week 14)

  2. Child Behavior Checklist (CBCL)

    Time frame: 1. Baseline 2. Post-treatment (on average week 14)

  3. Therapist Weekly Check-In

    Time frame: Weekly from the start of treatment (week 1) to post-treatment (an estimated average of week 14)

  4. Fidelity to PCIT and Fidelity to MY PCIT

    Fidelity to PCIT will be assessed across both conditions using previously validated measures developed by Dr. Eyberg for use with PCIT (Eyberg \& Members of the Child Study Laboratory, 1999). Independent coders, masked to condition, will score treatment fidelity via videotape observation. Fidelity to MY PCIT will also be assessed using procedures previously developed.

    Time frame: Weekly from the start of treatment (week 1) to post-treatment (an estimated average of week 14)

  5. My Thoughts about Therapy (MTT)

    Time frame: 1. Baseline 2. After CDI Teach (Week 1) 3. After PDI Teach (on average week 8) 4. Post-treatment (on average week 14)

Secondary outcomes

  1. Dyadic Parent Child Interaction Coding System-IV (DPICS)

    Time frame: 1. Baseline 2. Post-treatment (on average week 14)

  2. Parenting Stress Index (PSI)

    Time frame: 1. Baseline 2. Post-treatment (on average week 14)

  3. Therapy Attitude Inventory (TAI)

    Time frame: 1. After CDI Teach (Week 1) 2. After PDI Teach (on average week 8) 3. Post-treatment (on average week 14)

  4. Parent Explanatory Model - Treatment Explanatory Model Match (PEM-TEM Match)

    Time frame: 1. Baseline 2. After CDI Teach (Week 1) 3. After PDI Teach (on average week 8) 4. Post-treatment (on average week 14)

07

Study locations

2 sites
  • San Diego Center for Children
    San Diego, California 92111, United States
  • Rady Children's Hospital Outpatient Psychiatry
    San Diego, California 92123, United States
08

References and documents

Individual participant data

Plan to share: Yes — De-identified data will be submitted to the NIMH Data Archive (NDA) in accordance with applicable NIH and NIMH data-sharing requirements.

Time frame: De-identified data will be submitted and made available according to the timelines and procedures established by the NIMH Data Archive and the study's Data Management and Sharing Plan. Data will remain available for as long as they are maintained by the NDA.

Access criteria: Qualified researchers may request access to the de-identified data through the NIMH Data Archive.

Data sharing details ↗ · nda.nih.gov

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2027; primary completion for Dec 2028, 20 months later.

Of 232 non-industry interventional studies with no phase under Problem Behavior, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 43. This study's planned 20 months is below that.

Counting every sponsor, half of 235 studies reached it within 24 months; a quarter within 11 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 1, 2026
First posted
Oct 21, 2026
StartEst.
Apr 2027
Primary completionEst.
Dec 2028
CompletionEst.
Mar 2030
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07887295
Responsible party
Sponsor
First posted
Oct 21, 2026
Start date
Apr 2027 (estimated)
Primary completion
Dec 2028 (estimated)
Completion
Mar 2030 (estimated)
Last update
Oct 21, 2026

Study contacts

May Yeh, PhD
Contact
myeh@sdsu.edu
619-594-2838
Argero Zerr, PhD
Contact
argero.zerr@csuci.edu
805-437-3749
May Yeh
principal investigator · San Diego State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion